nodes	percent_of_prediction	percent_of_DWPC	metapath
Vigabatrin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000579	0.000579	CcSEcCtD
Vigabatrin—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000578	0.000578	CcSEcCtD
Vigabatrin—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000577	0.000577	CcSEcCtD
Vigabatrin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000577	0.000577	CcSEcCtD
Vigabatrin—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000576	0.000576	CcSEcCtD
Vigabatrin—Headache—Tretinoin—peripheral nervous system neoplasm	0.000575	0.000575	CcSEcCtD
Vigabatrin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000575	0.000575	CcSEcCtD
Vigabatrin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000574	0.000574	CcSEcCtD
Vigabatrin—Pain—Vincristine—peripheral nervous system neoplasm	0.000574	0.000574	CcSEcCtD
Vigabatrin—Constipation—Vincristine—peripheral nervous system neoplasm	0.000574	0.000574	CcSEcCtD
Vigabatrin—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000573	0.000573	CcSEcCtD
Vigabatrin—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000573	0.000573	CcSEcCtD
Vigabatrin—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000573	0.000573	CcSEcCtD
Vigabatrin—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000573	0.000573	CcSEcCtD
Vigabatrin—Rash—Melphalan—peripheral nervous system neoplasm	0.000572	0.000572	CcSEcCtD
Vigabatrin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000571	0.000571	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000569	0.000569	CcSEcCtD
Vigabatrin—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000567	0.000567	CcSEcCtD
Vigabatrin—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000566	0.000566	CcSEcCtD
Vigabatrin—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000564	0.000564	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000563	0.000563	CcSEcCtD
Vigabatrin—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00056	0.00056	CcSEcCtD
Vigabatrin—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.00056	0.00056	CcSEcCtD
Vigabatrin—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000558	0.000558	CcSEcCtD
Vigabatrin—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000554	0.000554	CcSEcCtD
Vigabatrin—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000554	0.000554	CcSEcCtD
Vigabatrin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000553	0.000553	CcSEcCtD
Vigabatrin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000553	0.000553	CcSEcCtD
Vigabatrin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00055	0.00055	CcSEcCtD
Vigabatrin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00055	0.00055	CcSEcCtD
Vigabatrin—Nausea—Topotecan—peripheral nervous system neoplasm	0.00055	0.00055	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000549	0.000549	CcSEcCtD
Vigabatrin—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000548	0.000548	CcSEcCtD
Vigabatrin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000546	0.000546	CcSEcCtD
Vigabatrin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000546	0.000546	CcSEcCtD
Vigabatrin—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000543	0.000543	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00054	0.00054	CcSEcCtD
Vigabatrin—Infection—Etoposide—peripheral nervous system neoplasm	0.00054	0.00054	CcSEcCtD
Vigabatrin—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000539	0.000539	CcSEcCtD
Vigabatrin—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000539	0.000539	CcSEcCtD
Vigabatrin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000539	0.000539	CcSEcCtD
Vigabatrin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000539	0.000539	CcSEcCtD
Vigabatrin—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000536	0.000536	CcSEcCtD
Vigabatrin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000533	0.000533	CcSEcCtD
Vigabatrin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00053	0.00053	CcSEcCtD
Vigabatrin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00053	0.00053	CcSEcCtD
Vigabatrin—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000528	0.000528	CcSEcCtD
Vigabatrin—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000524	0.000524	CcSEcCtD
Vigabatrin—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000518	0.000518	CcSEcCtD
Vigabatrin—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000516	0.000516	CcSEcCtD
Vigabatrin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000516	0.000516	CcSEcCtD
Vigabatrin—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000515	0.000515	CcSEcCtD
Vigabatrin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000514	0.000514	CcSEcCtD
Vigabatrin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000513	0.000513	CcSEcCtD
Vigabatrin—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000513	0.000513	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000512	0.000512	CcSEcCtD
Vigabatrin—Pain—Cisplatin—peripheral nervous system neoplasm	0.000507	0.000507	CcSEcCtD
Vigabatrin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.0005	0.0005	CcSEcCtD
Vigabatrin—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000499	0.000499	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000498	0.000498	CcSEcCtD
Vigabatrin—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000496	0.000496	CcSEcCtD
Vigabatrin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000494	0.000494	CcSEcCtD
Vigabatrin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000493	0.000493	CcSEcCtD
Vigabatrin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000489	0.000489	CcSEcCtD
Vigabatrin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000488	0.000488	CcSEcCtD
Vigabatrin—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000488	0.000488	CcSEcCtD
Vigabatrin—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000483	0.000483	CcSEcCtD
Vigabatrin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000481	0.000481	CcSEcCtD
Vigabatrin—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.00048	0.00048	CcSEcCtD
Vigabatrin—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000478	0.000478	CcSEcCtD
Vigabatrin—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000478	0.000478	CcSEcCtD
Vigabatrin—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000478	0.000478	CcSEcCtD
Vigabatrin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000477	0.000477	CcSEcCtD
Vigabatrin—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000477	0.000477	CcSEcCtD
Vigabatrin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000476	0.000476	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000474	0.000474	CcSEcCtD
Vigabatrin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000473	0.000473	CcSEcCtD
Vigabatrin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000472	0.000472	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000469	0.000469	CcSEcCtD
Vigabatrin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000469	0.000469	CcSEcCtD
Vigabatrin—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000469	0.000469	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000468	0.000468	CcSEcCtD
Vigabatrin—Pain—Etoposide—peripheral nervous system neoplasm	0.000465	0.000465	CcSEcCtD
Vigabatrin—Constipation—Etoposide—peripheral nervous system neoplasm	0.000465	0.000465	CcSEcCtD
Vigabatrin—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000464	0.000464	CcSEcCtD
Vigabatrin—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000464	0.000464	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000461	0.000461	CcSEcCtD
Vigabatrin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00046	0.00046	CcSEcCtD
Vigabatrin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000459	0.000459	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000452	0.000452	CcSEcCtD
Vigabatrin—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000451	0.000451	CcSEcCtD
Vigabatrin—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000448	0.000448	CcSEcCtD
Vigabatrin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000448	0.000448	CcSEcCtD
Vigabatrin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000446	0.000446	CcSEcCtD
Vigabatrin—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000445	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000444	0.000444	CcSEcCtD
Vigabatrin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000444	0.000444	CcSEcCtD
Vigabatrin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000443	0.000443	CcSEcCtD
Vigabatrin—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000442	0.000442	CcSEcCtD
Vigabatrin—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000442	0.000442	CcSEcCtD
Vigabatrin—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000442	0.000442	CcSEcCtD
Vigabatrin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000439	0.000439	CcSEcCtD
Vigabatrin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000439	0.000439	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000438	0.000438	CcSEcCtD
Vigabatrin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000437	0.000437	CcSEcCtD
Vigabatrin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000436	0.000436	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000433	0.000433	CcSEcCtD
Vigabatrin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000432	0.000432	CcSEcCtD
Vigabatrin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00043	0.00043	CcSEcCtD
Vigabatrin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00043	0.00043	CcSEcCtD
Vigabatrin—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00043	0.00043	CcSEcCtD
Vigabatrin—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.00043	0.00043	CcSEcCtD
Vigabatrin—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000427	0.000427	CcSEcCtD
Vigabatrin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000427	0.000427	CcSEcCtD
Vigabatrin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000426	0.000426	CcSEcCtD
Vigabatrin—Rash—Vincristine—peripheral nervous system neoplasm	0.000423	0.000423	CcSEcCtD
Vigabatrin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000423	0.000423	CcSEcCtD
Vigabatrin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000422	0.000422	CcSEcCtD
Vigabatrin—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000421	0.000421	CcSEcCtD
Vigabatrin—Headache—Vincristine—peripheral nervous system neoplasm	0.00042	0.00042	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000418	0.000418	CcSEcCtD
Vigabatrin—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000415	0.000415	CcSEcCtD
Vigabatrin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000414	0.000414	CcSEcCtD
Vigabatrin—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000413	0.000413	CcSEcCtD
Vigabatrin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000406	0.000406	CcSEcCtD
Vigabatrin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000405	0.000405	CcSEcCtD
Vigabatrin—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000401	0.000401	CcSEcCtD
Vigabatrin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.0004	0.0004	CcSEcCtD
Vigabatrin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.0004	0.0004	CcSEcCtD
Vigabatrin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000398	0.000398	CcSEcCtD
Vigabatrin—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000395	0.000395	CcSEcCtD
Vigabatrin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000391	0.000391	CcSEcCtD
Vigabatrin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00039	0.00039	CcSEcCtD
Vigabatrin—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.00039	CcSEcCtD
Vigabatrin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000384	0.000384	CcSEcCtD
Vigabatrin—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000382	0.000382	CcSEcCtD
Vigabatrin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000377	0.000377	CcSEcCtD
Vigabatrin—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000376	0.000376	CcSEcCtD
Vigabatrin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000375	0.000375	CcSEcCtD
Vigabatrin—Rash—Cisplatin—peripheral nervous system neoplasm	0.000374	0.000374	CcSEcCtD
Vigabatrin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000374	0.000374	CcSEcCtD
Vigabatrin—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000373	0.000373	CcSEcCtD
Vigabatrin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000372	0.000372	CcSEcCtD
Vigabatrin—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000371	0.000371	CcSEcCtD
Vigabatrin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.00037	0.00037	CcSEcCtD
Vigabatrin—Tension—Epirubicin—peripheral nervous system neoplasm	0.000366	0.000366	CcSEcCtD
Vigabatrin—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000363	0.000363	CcSEcCtD
Vigabatrin—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000361	0.000361	CcSEcCtD
Vigabatrin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000359	0.000359	CcSEcCtD
Vigabatrin—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000359	CcSEcCtD
Vigabatrin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000352	0.000352	CcSEcCtD
Vigabatrin—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000352	0.000352	CcSEcCtD
Vigabatrin—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.000348	CcSEcCtD
Vigabatrin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000346	0.000346	CcSEcCtD
Vigabatrin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000346	0.000346	CcSEcCtD
Vigabatrin—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000345	0.000345	CcSEcCtD
Vigabatrin—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000345	0.000345	CcSEcCtD
Vigabatrin—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000343	0.000343	CcSEcCtD
Vigabatrin—Rash—Etoposide—peripheral nervous system neoplasm	0.000343	0.000343	CcSEcCtD
Vigabatrin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000342	0.000342	CcSEcCtD
Vigabatrin—Headache—Etoposide—peripheral nervous system neoplasm	0.00034	0.00034	CcSEcCtD
Vigabatrin—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000339	0.000339	CcSEcCtD
Vigabatrin—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000337	0.000337	CcSEcCtD
Vigabatrin—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000335	0.000335	CcSEcCtD
Vigabatrin—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000335	CcSEcCtD
Vigabatrin—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.000334	CcSEcCtD
Vigabatrin—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000332	CcSEcCtD
Vigabatrin—Cough—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000326	CcSEcCtD
Vigabatrin—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000325	0.000325	CcSEcCtD
Vigabatrin—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000323	0.000323	CcSEcCtD
Vigabatrin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000323	0.000323	CcSEcCtD
Vigabatrin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.00032	CcSEcCtD
Vigabatrin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.000319	CcSEcCtD
Vigabatrin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000318	CcSEcCtD
Vigabatrin—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000318	CcSEcCtD
Vigabatrin—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000318	CcSEcCtD
Vigabatrin—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.000317	CcSEcCtD
Vigabatrin—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000317	0.000317	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000316	CcSEcCtD
Vigabatrin—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000314	0.000314	CcSEcCtD
Vigabatrin—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000311	0.000311	CcSEcCtD
Vigabatrin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.00031	CcSEcCtD
Vigabatrin—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000307	0.000307	CcSEcCtD
Vigabatrin—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000305	CcSEcCtD
Vigabatrin—Infection—Epirubicin—peripheral nervous system neoplasm	0.000303	0.000303	CcSEcCtD
Vigabatrin—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000301	CcSEcCtD
Vigabatrin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.000299	CcSEcCtD
Vigabatrin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000299	0.000299	CcSEcCtD
Vigabatrin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000296	CcSEcCtD
Vigabatrin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000294	CcSEcCtD
Vigabatrin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000294	CcSEcCtD
Vigabatrin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000294	CcSEcCtD
Vigabatrin—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.000293	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000292	CcSEcCtD
Vigabatrin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.000291	CcSEcCtD
Vigabatrin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.000284	CcSEcCtD
Vigabatrin—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000282	CcSEcCtD
Vigabatrin—Infection—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.00028	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000278	0.000278	CcSEcCtD
Vigabatrin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000276	CcSEcCtD
Vigabatrin—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000276	CcSEcCtD
Vigabatrin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000274	CcSEcCtD
Vigabatrin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000274	CcSEcCtD
Vigabatrin—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000271	CcSEcCtD
Vigabatrin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000268	CcSEcCtD
Vigabatrin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000265	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000263	CcSEcCtD
Vigabatrin—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000263	CcSEcCtD
Vigabatrin—Pain—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000261	CcSEcCtD
Vigabatrin—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000261	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000257	CcSEcCtD
Vigabatrin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000255	CcSEcCtD
Vigabatrin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000253	CcSEcCtD
Vigabatrin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000251	CcSEcCtD
Vigabatrin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000251	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000249	0.000249	CcSEcCtD
Vigabatrin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000248	CcSEcCtD
Vigabatrin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000245	0.000245	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000243	CcSEcCtD
Vigabatrin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000243	CcSEcCtD
Vigabatrin—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000242	CcSEcCtD
Vigabatrin—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000241	CcSEcCtD
Vigabatrin—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000241	CcSEcCtD
Vigabatrin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000241	CcSEcCtD
Vigabatrin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000241	0.000241	CcSEcCtD
Vigabatrin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000232	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.00023	CcSEcCtD
Vigabatrin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000224	CcSEcCtD
Vigabatrin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000224	CcSEcCtD
Vigabatrin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000223	CcSEcCtD
Vigabatrin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000223	0.000223	CcSEcCtD
Vigabatrin—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000219	CcSEcCtD
Vigabatrin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000216	CcSEcCtD
Vigabatrin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000208	CcSEcCtD
Vigabatrin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000208	CcSEcCtD
Vigabatrin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000202	CcSEcCtD
Vigabatrin—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000201	CcSEcCtD
Vigabatrin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000199	CcSEcCtD
Vigabatrin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000194	CcSEcCtD
Vigabatrin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000193	CcSEcCtD
Vigabatrin—Rash—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000192	CcSEcCtD
Vigabatrin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000192	CcSEcCtD
Vigabatrin—Headache—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000191	CcSEcCtD
Vigabatrin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000186	CcSEcCtD
Vigabatrin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000181	CcSEcCtD
Vigabatrin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000179	CcSEcCtD
Vigabatrin—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000178	CcSEcCtD
Vigabatrin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000178	CcSEcCtD
Vigabatrin—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000177	CcSEcCtD
Vigabatrin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000167	CcSEcCtD
